BACKGROUND: The human adiponectin gene has been implicated in the pathophysiology of obesity, type II diabetes mellitus, dyslipidemia and atherosclerosis. Investigation of the physiological functions of the adiponectin gene in humans was mainly conducted at the levels of plasma proteins or DNA polymorphisms. The depot-specific adiponectin mRNA levels also could be relevant to these physiological functions. OBJECTIVES: The relation between the adipose depot-specific adiponectin mRNA expression levels and various metabolic factors, including BMI, fasting plasma glucose, insulin, triglycerides (TGs) and HDL-cholesterol and insulin resistance index by HOMA, was investigated among 66 nondiabetic women using quantitative real-time PCR. RESULTS: The subcutaneous relative adiponectin mRNA levels (SRAmR) correlated significantly with the omental relative adiponectin mRNA levels (ORAmR) (gamma=0.468, P=0.0001). The SRAmR correlated inversely with the fasting plasma glucose with a borderline significance (gamma=-0.35, P=0.058). On the other hand, the ORAmR correlated negatively with serum TG levels with the adjustment for age (gamma=-0.33, P=0.007) or age plus BMI (gamma=-0.27, P=0.027). CONCLUSION: These results indicate that the adiponectin mRNA levels in different adipose depots were at least related to certain phenotypes of metabolic syndrome. The expression levels of adiponectin in the omental adipose depots are related to TG metabolism.
BACKGROUND: The humanadiponectin gene has been implicated in the pathophysiology of obesity, type II diabetes mellitus, dyslipidemia and atherosclerosis. Investigation of the physiological functions of the adiponectin gene in humans was mainly conducted at the levels of plasma proteins or DNA polymorphisms. The depot-specific adiponectin mRNA levels also could be relevant to these physiological functions. OBJECTIVES: The relation between the adipose depot-specific adiponectin mRNA expression levels and various metabolic factors, including BMI, fasting plasma glucose, insulin, triglycerides (TGs) and HDL-cholesterol and insulin resistance index by HOMA, was investigated among 66 nondiabetic women using quantitative real-time PCR. RESULTS: The subcutaneous relative adiponectin mRNA levels (SRAmR) correlated significantly with the omental relative adiponectin mRNA levels (ORAmR) (gamma=0.468, P=0.0001). The SRAmR correlated inversely with the fasting plasma glucose with a borderline significance (gamma=-0.35, P=0.058). On the other hand, the ORAmR correlated negatively with serum TG levels with the adjustment for age (gamma=-0.33, P=0.007) or age plus BMI (gamma=-0.27, P=0.027). CONCLUSION: These results indicate that the adiponectin mRNA levels in different adipose depots were at least related to certain phenotypes of metabolic syndrome. The expression levels of adiponectin in the omental adipose depots are related to TG metabolism.
Authors: S Kouidhi; S Jarboui; R Marrakchi; M-S Clerget Froidevaux; I Seugnet; H Abid; F Bchir; M Brahem; B Demeneix; H Guissouma; A Benammar Elgaaied Journal: J Endocrinol Invest Date: 2010-07-22 Impact factor: 4.256
Authors: Roser Ferrer; Eva Pardina; Joana Rossell; Laura Oller; Anna Viñas; Juan Antonio Baena-Fustegueras; Albert Lecube; Víctor Vargas; José María Balibrea; Enric Caubet; Oscar González; Ramón Vilallonga; Jose Manuel Fort; Julia Peinado-Onsurbe Journal: Obes Surg Date: 2015-08 Impact factor: 4.129
Authors: Susan A Phillips; Theodore P Ciaraldi; Deborah K Oh; Michelle K Savu; Robert R Henry Journal: Am J Physiol Endocrinol Metab Date: 2008-07-29 Impact factor: 4.310
Authors: Ana Paula Bazanelli; Maria Ayako Kamimura; Maria Eugenia Fernandes Canziani; Silvia Regina Manfredi; Lilian Cuppari Journal: Perit Dial Int Date: 2012-09-01 Impact factor: 1.756
Authors: Juan Jose Hernandez-Morante; Fermin Ignacio Milagro; Elvira Larque; Juan Lujan; Jose Alfredo Martinez; Salvador Zamora; Marta Garaulet Journal: Obes Surg Date: 2007-04 Impact factor: 4.129
Authors: Shilpa H Jain; Joseph M Massaro; Udo Hoffmann; Guido A Rosito; Ramachandran S Vasan; Annaswamy Raji; Christopher J O'Donnell; James B Meigs; Caroline S Fox Journal: Diabetes Care Date: 2009-02-17 Impact factor: 19.112